Interpretation of Mycobacterium tuberculosis antigen-specific IFN-γ release assays (T-SPOT.TB) and factors that may modulate test results

Journal of Infection

Volumn 55, Issue 2, 2007, Pages 169-173

  Dheda, K ^a,b   Pooran, A ^b   Pai, M ^d   Miller, R F ^c   Lesley, K ^b   Booth, H L ^c   Scott, G M ^c   Akbar, A N ^c   Zumla, A ^b   Rook, G A ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c NATIONAL HEALTH SERVICE   (United Kingdom)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

CFP 10; ESAT 6; Human; IFN ; Tuberculosis

Indexed keywords

ENDOTOXIN; GAMMA INTERFERON; PEPTIDE; PROTEIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE MARKER; DRUG RESPONSE; ENVIRONMENTAL FACTOR; HOST; HUMAN; IMMUNOASSAY; INCUBATION TIME; MYCOBACTERIUM TUBERCULOSIS; STANDARDIZATION; TREATMENT DURATION; TUBERCULOSIS;

ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; FEMALE; HUMANS; INTERFERON TYPE II; MALE; SOUTH AFRICA; TUBERCULOSIS, PULMONARY;

EID: 34447093772     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2007.02.005     Document Type: Article

References (20)

1. Dogra S., Narang P., Mendiratta D.K., Chaturvedi P., Reingold A.L., Colford Jr. J.M., et al. Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J Infect 54 3 (2007) 267-276
2. Dheda K., Udwadia Z.F., Huggett J.F., Johnson M.A., and Rook G.A. Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis. Curr Opin Pulm Med 11 (2005) 195-202
3. Carrara S., Vincenti D., Petrosillo N., Amicosante M., Girardi E., and Goletti D. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis 38 (2004) 754-756
4. Lalvani A., Nagvenkar P., Udwadia Z., Pathan A.A., Wilkinson K.A., Shastri J.S., et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 183 (2001) 469-477
5. Pathan A.A., Wilkinson K.A., Klenerman P., McShane H., Davidson R.N., Pasvol G., et al. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 167 (2001) 5217-5225
6. Aiken A.M., Hill P.C., Fox A., McAdam K.P., Jackson-Sillah D.J., Lugos M.D., et al. Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis 6 (2006) 66
7. Al-Attiyah R., Mustafa A.S., Abal A.T., Madi N.M., and Andersen P. Restoration of mycobacterial antigen-induced proliferation and interferon-gamma responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy. FEMS Immunol Med Microbiol 38 (2003) 249-256
8. Ferrand R.A., Bothamley G.H., Whelan A., and Dockrell H.M. Interferon-gamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment. Int J Tuberc Lung Dis 9 (2005) 1034-1039
9. Ulrichs T., Anding R., Kaufmann S.H., and Munk M.E. Numbers of IFN-gamma-producing cells against ESAT-6 increase in tuberculosis patients during chemotherapy. Int J Tuberc Lung Dis 4 (2000) 1181-1183
10. Vekemans J., Lienhardt C., Sillah J.S., Wheeler J.G., Lahai G.P., Doherty M.T., et al. Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun 69 (2001) 6554-6557
11. Wu-Hsieh B.A., Chen C.K., Chang J.H., Lai S.Y., Wu C.H., Cheng W.C., et al. Long-lived immune response to early secretory antigenic target 6 in individuals who had recovered from tuberculosis. Clin Infect Dis 33 (2001) 1336-1340
12. Kaech S.M., Wherry E.J., and Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2 (2002) 251
13. Hsu T., Hingley-Wilson S.M., Chen B., Chen M., Dai A.Z., Morin P.M., et al. The primary mechanism of attenuation of Bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc Natl Acad Sci USA 100 (2003) 12420
14. Dheda K., Chang J.S., Kim L.U., Huggett J.F., Johnson M.A., Zumla A., et al. Interferon gamma assays for tuberculosis. Lancet Infect Dis 5 (2005) 324-325 [author reply 325-7]
15. Jansky L., Reymanova P., and Kopecky J. Dynamics of cytokine production in human peripheral blood mononuclear cells stimulated by LPS or infected by Borrelia. Physiol Res 52 (2003) 593-598
16. Arend S.M., Geluk A., van Meijgaarden K.E., van Dissel J.T., Theisen M., Andersen P., et al. Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides. Infect Immun 68 (2000) 3314-3321
17. de Jong B.C., Hill P.C., Brookes R.H., Gagneux S., Jeffries D.J., Otu J.K., et al. Mycobacterium africanum elicits an attenuated T cell response to early secreted antigenic target, 6 kDa, in patients with tuberculosis and their household contacts. J Infect Dis 193 (2006) 1279-1286
18. Harari A., Vallelian F., Meylan P.R., and Pantaleo G. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J Immunol 174 (2005) 1037-1045
19. Pai M., Joshi R., Dogra S., Mendiratta D.K., Narang P., Dheda K., et al. Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report. J Occup Med Toxicol 1 (2006) 7
20. Ferrara G., Losi M., D'Amico R., Roversi P., Piro R., Meacci M., et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 367 (2006) 1328-1334